EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

A review of multidisciplinary care in metabolic dysfunction‐associated steatohepatitis and cardiometabolic disease, with a focus on Canada

James Kim iD, Paolo Raggi iD, Anne-Marie Carreau iD, Sean Wharton iD, Alice Y Y Cheng iD, Mark G Swain iD

Diabetes, Obesity and Metabolism · 2025

DOI: 10.1111/dom.70117 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Diabetes, Obesity and Metabolism, 2025. Verfasst von James Kim und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Family Medicine, University of Calgary, Calgary, Alberta, Canada. Hauptthemen laut MEDLINE: Patient Care Team, Diabetes Mellitus, Type 2, Obesity, Cardiovascular Diseases. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 120 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Novo Nordisk.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cardiometabolic disease (CMD) is associated with an increased risk of metabolic dysfunction‐associated steatohepatitis (MASH). Most patients develop MASH in association with type 2 diabetes and obesity. Optimal disease management requires effective multidisciplinary collaboration between primary care physicians and specialists from different medical fields; however, awareness of the risks, association with CMD, diagnosis, complications, and management strategies of MASH is low among non‐liver specialists. In Canada, variable access to diagnostic testing and, until recently, the lack of national MASH guidelines, are also barriers to effective disease management. Ongoing cross‐disciplinary education and wide systemic changes are required to ensure timely patient identification and the establishment of holistic patient care pathways that can begin to address MASH and associated CMD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Patient Care TeamDiabetes Mellitus, Type 2ObesityCardiovascular DiseasesNon-alcoholic Fatty Liver DiseaseFatty LiverMetabolic SyndromeMetabolic DiseasesHumansCanada

Stichwörter der Autor:innen

cardiovascular diseasefatty liver diseaseliverobesity careprimary care

Autor:innen und Institutionen

  • Department of Family Medicine, University of Calgary, Calgary, Alberta, Canada.
  • Department of Medicine and Division of Cardiology, University of Alberta, Edmonton, Alberta, Canada.
  • Department of Medicine, Faculté de Médecine, Université Laval, Quebec, Quebec, Canada.
  • Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.
  • The Wharton Medical Clinic & Diabetes Management, Burlington, Ontario, Canada.
  • Department of Medicine, Trillium Health Partners and St Michael's Hospital, University of Toronto, Toronto, Ontario, Canada.

ORCID-Profile: James Kim, Paolo Raggi, Anne-Marie Carreau, Sean Wharton, Alice Y Y Cheng, Mark G Swain

Förderung

  • Novo Nordisk

Zitieren

APA

Kim, J., Raggi, P., Carreau, A. M., Wharton, S., Cheng, A. Y. Y., & Swain, M. G. (2025). A review of multidisciplinary care in metabolic dysfunction‐associated steatohepatitis and cardiometabolic disease, with a focus on Canada. Diabetes, Obesity and Metabolism. https://doi.org/10.1111/dom.70117

Vancouver

Kim J, Raggi P, Carreau AM, Wharton S, Cheng AYY, Swain MG. A review of multidisciplinary care in metabolic dysfunction‐associated steatohepatitis and cardiometabolic disease, with a focus on Canada. Diabetes, Obesity and Metabolism. 2025. doi:10.1111/dom.70117

BibTeX
@article{Kim2025,
  author = {Kim, James and Raggi, Paolo and Carreau, Anne-Marie and Wharton, Sean and Cheng, Alice Y Y and Swain, Mark G},
  title = {A review of multidisciplinary care in metabolic dysfunction‐associated steatohepatitis and cardiometabolic disease, with a focus on Canada},
  journal = {Diabetes, Obesity and Metabolism},
  year = {2025},
  doi = {10.1111/dom.70117}
}
Kostenlos starten →